Neoadjuvantes osimertinib mit/ohne chemotherapie vs.chemotherapie bei EGFRmutiertem resektablem NSCLC: NeoADAURA Meeting Abstract
| Authors: | Griesinger, F.; Tsuboi, M.; Weder, W.; Escriu, C.; Blakely, C.; He, J.; Dacic, S.; Yatabe, Y.; Zeng, L.; Walding, A.; Chaft, J. |
| Abstract Title: | Neoadjuvantes osimertinib mit/ohne chemotherapie vs.chemotherapie bei EGFRmutiertem resektablem NSCLC: NeoADAURA |
| Meeting Title: | Congress of the German Society for Pulmonology and Respiratory Medicine |
| Journal Title: | Pneumologie |
| Volume: | 75 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Jun 2-10 |
| Meeting Location: | Virtual |
| ISSN: | 0934-8387 |
| Publisher: | Georg Thieme Verlag Kg |
| Date Published: | 2021-04-01 |
| Start Page: | S6 |
| End Page: | S7 |
| Language: | German |
| ACCESSION: | WOS:000645825800006 |
| DOI: | 10.1055/s-0041-1723275 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P610 -- "Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy in patients with EGFR-mutated resectable NSCLC: NeoADAURA" -- Source: Wos |
